HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Chaman Saini Selected Research

interleukin-21 (interleukin 21)

1/2022IL-21 plays an important role in modulating "Th17-Treg" cell axis in leprosy Type 1 reactions.
4/2016Leprosy Reactions Show Increased Th17 Cell Activity and Reduced FOXP3+ Tregs with Concomitant Decrease in TGF-β and Increase in IL-6.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Chaman Saini Research Topics

Disease

12Leprosy (Hansen's Disease)
01/2022 - 01/2013
6Inflammation (Inflammations)
01/2022 - 04/2016
4Lepromatous Leprosy
01/2020 - 01/2013
3Tuberculoid Leprosy
01/2018 - 01/2013
2Disease Progression
01/2020 - 01/2017
1Infections
01/2022
1Cytokine Release Syndrome
01/2022
1COVID-19
01/2022
1Multiple Organ Failure (MODS)
01/2022
1Cutaneous Tuberculosis (Scrofuloderma)
01/2018
1Autoimmune Diseases (Autoimmune Disease)
04/2016
1Erythema Nodosum
05/2013

Drug/Important Bio-Agent (IBA)

10Interleukin-17 (Interleukin 17)IBA
01/2020 - 01/2013
8CytokinesIBA
01/2022 - 01/2013
4Interleukin-10 (Interleukin 10)IBA
01/2020 - 01/2017
3AntigensIBA
04/2016 - 01/2013
2interleukin-21 (interleukin 21)IBA
01/2022 - 04/2016
2Interleukin-6 (Interleukin 6)IBA
01/2020 - 04/2016
2Proteins (Proteins, Gene)FDA Link
01/2018 - 05/2013
2Interleukin-23 (Interleukin 23)IBA
01/2017 - 04/2016
1Intravenous Immunoglobulins (IVIG)FDA Link
01/2022
1Interleukin-12 (IL 12)IBA
01/2017
1LigandsIBA
01/2017
1ChemokinesIBA
04/2016
1MitogensIBA
01/2014
1Interferon-gamma (Interferon, gamma)IBA
05/2013
1Peptides (Polypeptides)IBA
05/2013
1InterferonsIBA
01/2013
1Interleukin-4 (Interleukin 4)IBA
01/2013
1Protein Isoforms (Isoforms)IBA
01/2013

Therapy/Procedure

2Therapeutics
01/2022 - 01/2017
1Immunotherapy
01/2018